Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120763 · ClinicalTrials.gov registry record · Phase 3
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
A Phase 3 study of Pain Control and Distal Radius Fracture Reduction, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07120763: Recruiting Phase 3 study of Pain Control and Distal Radius Fracture Reduction, sponsored by State University of New York at Buffalo.
NCT07120763 is a Phase 3 study of Pain Control and Distal Radius Fracture Reduction that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 50 participants, above the 35-participant average among 3 other Pain Control trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07120763, a Phase 3 study of Pain Control and Distal Radius Fracture Reduction, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric patients presenting with distal radius fractures requiring reduction, compared to control of standard full conscious sedation using ketamine.
Primary Outcome
Including control group of patients treated with full ketamine sedation in setting of distal radius fracture reduction; randomization of patients deemed safe for full sedation to either control group, or one of two intervention groups including (group 1) hematoma block/minimal ketamine pain control (0.25mg/kg), and (group 2) intranasal fentanyl and hematoma block, utilized in the setting of distal radius fractures in pediatric patients requiring reduction. The investigators will be obtaining Vis
Conditions Studied
Interventions
- DRUG Ketamine + Lidocaine
- DRUG Ketamine group
- DRUG Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)
Study Locations (1)
New York
- Oshei Children's Hospital - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-22 |
| Est. Completion | 2027-08-22 |
| Phase | Phase 3 |
What NCT07120763 shows while recruiting
NCT07120763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 35-participant average among 3 other Pain Control trials with a reported enrollment target (43% higher).
The record links to 3 conditions, with Pain Control appearing as the primary indexed condition, and to 3 interventions - of which Ketamine + Lidocaine is the first listed.
NCT07120763 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07120763 about?
NCT07120763 is a clinical study titled "Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures". The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric patients presenting with distal radius fractures requiring reduction, compared to control of standard full conscious sedation using ketamine.
What is the current status of trial NCT07120763?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2025-08-22. Estimated completion is 2027-08-22.
What conditions does trial NCT07120763 study?
This clinical trial studies the following conditions: Pain Control, Distal Radius Fracture Reduction, Pediatric Fractures.
What interventions are being tested in trial NCT07120763?
The interventions under investigation include: Ketamine + Lidocaine (DRUG), Ketamine group (DRUG), Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray) (DRUG).
Who is sponsoring clinical trial NCT07120763?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120763 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI